Literature DB >> 14966253

Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin.

A Juhani Kahri, Miia M Valkonen, Matti K E Vuoristo, Pertti J Pentikäinen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14966253     DOI： 10.1345/aph.1D243

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  8 in total

1.  Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin.

Authors:  Judith Wagner; Christine Suessmair; Hans-Walter Pfister
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

2.  [Rhabdomyolysis after administration of diclofenac].

Authors:  K Knobloch; D Rossner; T Gössling; A Lichtenberg; M Richter; C Krettek
Journal:  Unfallchirurg       Date:  2005-05       Impact factor: 1.000

Review 3.  Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.

Authors:  Pertti J Neuvonen; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 4.  Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management.

Authors:  Zhining Wen; Yu Liang; Yingyi Hao; Brian Delavan; Ruili Huang; Mike Mikailov; Weida Tong; Menglong Li; Zhichao Liu
Journal:  Drug Discov Today       Date:  2018-06-11       Impact factor: 7.851

Review 5.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

6.  Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand.

Authors:  Thananan Rattanachotphanit; Chulaporn Limwattananon; Onanong Waleekhachonloet
Journal:  Ther Adv Drug Saf       Date:  2019-01-30

7.  The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies.

Authors:  Abdallah Abu Mellal; Nadia Hussain; Amira Sa Said
Journal:  Ther Clin Risk Manag       Date:  2019-07-23       Impact factor: 2.423

8.  A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.

Authors:  Bita Mesgarpour; Ghazaleh Gouya; Harald Herkner; Berthold Reichardt; Michael Wolzt
Journal:  Lipids Health Dis       Date:  2015-10-24       Impact factor: 3.876
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.